See also this year's filing and all EDGAR filings for this company.
PDF Report 0001460702_2023_Qualigen_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001460702, Qualigen Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 10,820,538 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 6,471,304 |
| 2 | PropertyPlantAndEquipmentNet | 345,087 |
| 3 | remainder_Assets | 1,446,562 |
| 4 | LiabilitiesCurrent | 8,608,169 |
| 5 | LiabilitiesNoncurrent | 1,301,919 |
| 6 | remainder_Liabilities | 406,813 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 10,835,647 |
| 9 | ResearchAndDevelopmentExpense | 6,837,133 |
| 10 | remainder_Expenses | 9,227,101 |
| 11 | remainder_Revenues | 4,983,556 |
| 12 | remainder_NetIncome | 881,682 |
| 13 | remainder_ComprehensiveNetIncome | 2,444,821 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 19,083,491 |
| 1 | Liabilities | 10,316,901 |
| 2 | Expenses | 26,899,881 |
| 3 | Revenues | 4,983,556 |
| 4 | StockholdersEquity | 8,766,590 |
| 5 | NetIncome | -21,034,643 |
| 6 | ComprehensiveNetIncome | -19,812,232 |
| 7 | BaseVar | 32,305,166 |
| 8 | EconomicCapitalRatio | -0.322 |
Edgar->Model Mapping
Feature Distribution
Change over Time
